688363 華熙生物
按盤價 
50.560 +0.510 (+1.019%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 3,874,744 | -8.21% | 6,075,924 | 6,359,192 | 4,947,774 | 2,632,734 | |
| 減：營業總成本 | 3,419,166 | -7.48% | 5,438,234 | 5,322,193 | 4,165,938 | 1,925,485 | |
| 其中:營業成本 | 1,010,188 | -11.13% | 1,621,028 | 1,463,227 | 1,085,252 | 489,470 | |
| 財務費用 | (7,136) | -71.45% | (30,795) | (48,657) | (495) | (512) | |
| 資產減值損失 | (18,154) | 376.09% | (54,403) | (15,447) | (29,828) | (16,257) | |
| 公允價值變動收益 | 32 | -86.39% | 1,468 | (143) | 7,394 | 3,339 | |
| 投資收益 | (4,996) | -369.49% | 1,327 | 11,915 | 20,646 | 34,177 | |
| 其中：對聯營企業和合營企業的投資收益 | (6,136) | 322.19% | (1,652) | (2,360) | (344) | (5,964) | |
| 營業利潤 | 436,125 | -28.64% | 708,386 | 1,136,314 | 905,553 | 757,048 | |
| 利潤總額 | 436,569 | -28.48% | 701,722 | 1,136,112 | 890,199 | 758,898 | |
| 減：所得稅費用 | 77,519 | -24.99% | 118,980 | 174,732 | 114,643 | 113,887 | |
| 淨利潤 | 359,050 | -29.19% | 582,742 | 961,380 | 775,556 | 645,011 | |
| 減：非控股權益 | (2,974) | -59.36% | (9,814) | (9,538) | (6,779) | (828) | |
| 股東淨利潤 | 362,024 | -29.62% | 592,556 | 970,919 | 782,335 | 645,839 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.750 | -29.91% | 1.230 | 2.020 | 1.630 | 1.350 | |
| 每股派息 (元) * | -- | -- | 0.380 | 0.610 | 0.490 | 0.410 | |
| 每股淨資產 (元) * | 14.571 | 1.34% | 14.416 | 13.789 | 11.873 | 10.458 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 14/02/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
